<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03646929</url>
  </required_header>
  <id_info>
    <org_study_id>2017-01893; me18Hardmeier</org_study_id>
    <nct_id>NCT03646929</nct_id>
  </id_info>
  <brief_title>Motor Evoked Potentials With Modified Facilitation Technique</brief_title>
  <acronym>EP-F</acronym>
  <official_title>Motor Evoked Potentials With Modified Facilitation Technique: Normative Data and Reliability in Healthy Individuals and Comparison of Sensitivity and Specificity With Standard Technique in Patients With Multiple Sclerosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Basel, Switzerland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Investigating the change in Test- Retest- reliability in healthy individuals when applying a
      modified easy to use facilitation technique compared to standard facilitation technique and
      analyzing sensitivity and specificity in patients with multiple sclerosis regarding detection
      of pathologic results
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 20, 2017</start_date>
  <completion_date type="Anticipated">October 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Test- Re-Test reliability when using modified facilitation technique (compared to standard facilitation technique) in healthy individuals</measure>
    <time_frame>measuring time 2 (75 minutes) maximal 1 month later than measuring time 1 (75 minutes)</time_frame>
    <description>Determination of mean intra-individual difference between measuring time 1 and measuring time 2 and calculation of standard deviation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>comparison of sensitivity and specificity of modified facilitation technique and standard facilitation technique in patients with multiple sclerosis</measure>
    <time_frame>1 measuring time (90 minutes)</time_frame>
    <description>Determination on the basis of the standard values (established in healthy individuals) in how many patients a pathological result with the modified facilitation technique and the standard facilitation technique is present. Using a a cross-tabulation, the sensitivity and specificity of the modified facilitating technique compared to the standard facilitation technique is measured</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Multiple Sclerosis</condition>
  <arm_group>
    <arm_group_label>healthy individuals and patients with multiple sclerosis</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>MEP in healthy individuals and patients with multiple sclerosis are measured using standard facilitation technique</description>
  </arm_group>
  <arm_group>
    <arm_group_label>patients with multiple sclerosis</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>MEP in patients with multiple sclerosis are measured using modified facilitation technique</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>MEP using standard facilitation technique</intervention_name>
    <description>measuring of MEP using standard facilitation technique according to the Guidelines of International Federation of Clinical Neurophysiology</description>
    <arm_group_label>healthy individuals and patients with multiple sclerosis</arm_group_label>
    <arm_group_label>patients with multiple sclerosis</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>MEP using modified facilitation technique</intervention_name>
    <description>measuring of MEP using modified facilitation technique (application of additional 8-12x magnetic stimuli for arms and legs)</description>
    <arm_group_label>patients with multiple sclerosis</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria for healthy individuals:

          -  Ability to understand the purpose and risks of the study, provide signed and dated
             informed consent

          -  Between 18 and 65 year of age

          -  No neurologic or psychiatric comorbidity requiring continous treatment

          -  No previous damage of central nervous System

        Inclusion Criteria for patients:

          -  Ability to understand the purpose and risks of the study, provide signed and dated
             informed consent

          -  Between 18 and 65 year of age

          -  patients with inflammatory diseases of the central nervous system (CNS) or multiple
             sclerosis appointed for routine MEP diagnostic at the Department of Clinical
             Neurophysiology, University Hospital Basel

        Exclusion Criteria:

          -  Contraindication for measuring of motoric evoked potentials (MEP): metal implants
             (pacemaker, stents); known epilepsy oder previous epileptic fit

          -  Known disease of the peripheral nervous system (polyneuropathy)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martin Hardmeier, PD Dr. med</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Basel, Switzerland</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Martin Hardmeier, PD Dr. med</last_name>
    <phone>+41 61 556 5435</phone>
    <email>martin.hardmeier@usb.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Julia Opiatka</last_name>
    <email>julia.opiatka@stud.unibas.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Dep. of Neurology and Clinical Neurophysiology , Hospital of the University of Basel</name>
      <address>
        <city>Basel</city>
        <zip>4031</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Fuhr, Prof.</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>August 22, 2018</study_first_submitted>
  <study_first_submitted_qc>August 22, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 24, 2018</study_first_posted>
  <last_update_submitted>December 9, 2019</last_update_submitted>
  <last_update_submitted_qc>December 9, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 10, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>facilitation technique</keyword>
  <keyword>multimodal evoked potentials (mmEP) in multiple sclerosis</keyword>
  <keyword>motor evoked potential (MEP) in multiple sclerosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Multiple Sclerosis</mesh_term>
    <mesh_term>Sclerosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

